{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:16:20Z","timestamp":1761495380135,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.clim.2023.109269","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T05:38:22Z","timestamp":1676525902000},"page":"109269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Minimal dose of hematopoietic stem cell transplantation without myelosuppressive conditioning for T-B+NK- severe combined immunodeficiency"],"prefix":"10.1016","volume":"248","author":[{"given":"Eun Sang","family":"Yi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Young","family":"Ju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Won","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki Woong","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong Hoe","family":"Koo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun-Suk","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang Mo","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yae-Jean","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keon Hee","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2018","key":"10.1016\/j.clim.2023.109269_bb0005","first-page":"96","article-title":"Primary immunodeficiency diseases committee report on inborn errors of immunity","volume":"38","author":"Picard","year":"2017","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2023.109269_bb0010","doi-asserted-by":"crossref","first-page":"e239","DOI":"10.1016\/S2352-3026(19)30021-3","article-title":"Lentiviral haemopoietic stem\/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1\/2 clinical study","volume":"6","author":"Ferrua","year":"2019","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.clim.2023.109269_bb0015","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJMoa1815408","article-title":"Lentiviral gene therapy combined with low-dose busulfan in infants with SCID-X1","volume":"380","author":"Mamcarz","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2023.109269_bb0020","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMoa0805817","article-title":"Gene therapy for immunodeficiency due to adenosine deaminase deficiency","volume":"360","author":"Aiuti","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2023.109269_bb0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1182\/blood-2016-01-688226","article-title":"Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency","volume":"128","author":"Cicalese","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.clim.2023.109269_bb0030","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJMoa2027675","article-title":"Autologous ex vivo lentiviral gene therapy for adenosine deaminase deficiency","volume":"384","author":"Kohn","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2023.109269_bb0035","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.jaci.2014.02.042","article-title":"Host natural killer immunity is a key indicator of permissiveness for donor cell engraftment in patients with severe combined immunodeficiency","volume":"133","author":"Hassan","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2023.109269_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2009.07.049","article-title":"Long-term clinical outcome of patients with severe combined immunodeficiency who received related donor bone marrow transplants without pretransplant chemotherapy or post-transplant GVHD prophylaxis","volume":"155","author":"Railey","year":"2009","journal-title":"J. Pediatr."},{"key":"10.1016\/j.clim.2023.109269_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109084","article-title":"Advances in the treatment of severe combined immunodeficiency","volume":"242","author":"Slatter","year":"2022","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2023.109269_bb0050","series-title":"Thomas, 1994 Consensus Conference on Acute GVHD Grading, Bone Marrow Transplant","first-page":"825","volume":"vol. 15","year":"1995"},{"key":"10.1016\/j.clim.2023.109269_bb0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.blre.2005.01.007","article-title":"Chronic graft-versus-host disease","volume":"20","author":"Horwitz","year":"2006","journal-title":"Blood Rev."},{"key":"10.1016\/j.clim.2023.109269_bb0060","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1038\/sj.leu.2404335","article-title":"Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning","volume":"20","author":"Baron","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.clim.2023.109269_bb0065","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1182\/blood-2006-07-029090","article-title":"Long-term T-cell reconstitution after hematopoietic stem-cell transplantation in primary T-cell-immunodeficient patients is associated with myeloid chimerism and possibly the primary disease phenotype","volume":"109","author":"Cavazzana-Calvo","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.clim.2023.109269_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2014.06.021","article-title":"Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency","volume":"134","author":"Dvorak","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2023.109269_bb0075","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1182\/blood-2017-05-781849","article-title":"Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study","volume":"130","author":"Heimall","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.clim.2023.109269_bb0080","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1038\/s41409-021-01378-8","article-title":"EBMT\/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity","volume":"56","author":"Lankester","year":"2021","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.clim.2023.109269_bb0085","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1056\/NEJMoa1401177","article-title":"Transplantation outcomes for severe combined immunodeficiency, 2000-2009","volume":"371","author":"Pai","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2023.109269_bb0090","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jaci.2013.01.047","article-title":"B-cell reconstitution for SCID: should a conditioning regimen be used in SCID treatment?","volume":"131","author":"Haddad","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2023.109269_bb0095","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1182\/blood-2014-06-579680","article-title":"Chemotherapy-free conditioning: one step closer","volume":"124","author":"Gennery","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.clim.2023.109269_bb0100","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1007\/s10875-022-01262-0","article-title":"Clinical and laboratory factors affecting the prognosis of severe combined immunodeficiency","volume":"42","author":"Ozturk","year":"2022","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2023.109269_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2021.10.017","article-title":"Hematopoietic cell transplantation in severe combined immunodeficiency: the SCETIDE 2006-2014 European cohort","volume":"149","author":"Lankester","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2023.109269_bb0110","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2011-12-396879","article-title":"Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency","volume":"120","author":"Hassan","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clim.2023.109269_bb0115","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1182\/blood-2016-11-745638","article-title":"Reticular dysgenesis: international survey on clinical presentation, transplantation, and outcome","volume":"129","author":"Hoenig","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.clim.2023.109269_bb0120","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s10875-018-0542-7","article-title":"Allogeneic hematopoietic cell transplantation in patients with primary Immunodeficiencies in Korea: eleven-year experience in a single center","volume":"38","author":"Yi","year":"2018","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2023.109269_bb0125","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1097\/MPH.0000000000000352","article-title":"Hematopoietic stem cell transplantations for primary immune deficiencies: 3 decades of experience from a tertiary medical center","volume":"37","author":"Rousso","year":"2015","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.clim.2023.109269_bb0130","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1182\/blood-2018-03-840702","article-title":"SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery","volume":"132","author":"Haddad","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.clim.2023.109269_bb0135","doi-asserted-by":"crossref","first-page":"S289","DOI":"10.1016\/j.bbmt.2014.11.459","article-title":"Early hematopoietic cell transplant (HCT) outcomes of children with severe combined immunodeficiency disease (SCID): the first seventy four patients of the primary immune deficiency treatment consortium (PIDTC) prospective study 6901","volume":"21","author":"Heimall","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.clim.2023.109269_bb0140","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s10875-021-01112-5","article-title":"Hematopoietic cell transplantation for severe combined immunodeficiency patients: a Japanese retrospective study","volume":"41","author":"Miyamoto","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2023.109269_bb0145","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/jama.295.5.508","article-title":"Bone marrow transplantation for severe combined immune deficiency","volume":"295","author":"Grunebaum","year":"2006","journal-title":"Jama"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661623000487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661623000487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:08:55Z","timestamp":1761494935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661623000487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":29,"alternative-id":["S1521661623000487"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2023.109269","relation":{},"ISSN":["1521-6616"],"issn-type":[{"type":"print","value":"1521-6616"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Minimal dose of hematopoietic stem cell transplantation without myelosuppressive conditioning for T-B+NK- severe combined immunodeficiency","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2023.109269","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109269"}}